Cancer CAFL

Rife Frequencies for

Frequency Player

Volume: 50%
Waveform:

About This Program

Cancer is a broad term for a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can affect virtually any tissue or organ in the body. In Rife frequency therapy, the Cancer CAFL program draws on frequencies compiled by the Consolidated Annotated Frequency List, a community-gathered reference used by Rife practitioners for decades. The approach involves exposing the body to specific electromagnetic frequencies believed to target abnormal cellular activity, support immune function, and promote the body's natural restorative processes. Because all frequencies in this program play simultaneously, the session delivers a layered frequency environment intended to address multiple aspects of cellular stress at once. Rife therapy is considered a complementary, non-invasive modality and is not a substitute for conventional oncology care. Users exploring this program typically do so alongside existing treatment plans, seeking additional support for overall well-being and symptom comfort. As with any health-related practice, it is strongly advised to consult a qualified healthcare practitioner before beginning frequency therapy, particularly when managing a serious condition such as cancer.

Frequencies (10)

  • 6.8 Hz
  • 20 Hz
  • 55.56 Hz
  • 440 Hz
  • 663 Hz
  • 778 Hz
  • 1050 Hz
  • 1550 Hz
  • 2180 Hz
  • 3672 Hz

Related Cancer Support Programs

View all Cancer Support programs →

Run all 10 Cancer CAFL frequencies at once

RifePlayer plays every Cancer CAFL frequency simultaneously — the fastest way to run a cancer support program, finishing in minutes instead of hours. Experience the full power of frequency therapy with our advanced multi-frequency technology.

⚡ Instant access • 🎯 All frequencies • ⏱️ Faster treatments

Ready to start your healing journey?

Experience the power of rife frequency therapy with RifePlayer - the easiest way to use rife frequencies for your wellness.